The FDA is phasing out animal testing and moving to more human-relevant methods. This was announced as one of Marty Makary’s ...

Animal testing requirements for monoclonal antibodies and other medications will be “reduced, refined or potentially replaced ...

This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...

The FDA announced it will be reducing, refining and potentially replacing the animal testing requirement for the approval of ...

Andrei Georgescu of Vivodyne discusses key advantages of its humanized drug testing platform and the impact of the FDA’s ...

The FDA is shifting towards a more human-relevant approach to drug testing, encouraging the use of New Approach Methodologies such as laboratory-grown human cell models, organ-on-a-chip systems, ...

The FDA will begin promoting computer-based and lab-grown drug testing models to reduce the cost, time, and ethical burden of drug testing.

"We are excited to see that the FDA is elevating its continued commitment to reduce animal testing through innovative science, as outlined in the new Roadmap to Reducing Animal Testing in Preclinical ...

Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced a major milestone ...

Chinese CRO GemPharmatech is building up its U.S. presence with a new San Diego space housing laboratories and a suite of genetically engineered mouse models. The new facility is an expansion of ...

In January, the FDA released a warning letter about a new canine allergy drug called Zenrelia. The letter updated safety ...